<DOC>
	<DOCNO>NCT02860507</DOCNO>
	<brief_summary>The purpose study evaluate efficacy Sugammadex rapidly reverse deep neuromuscular blockade ( induced rocuronium )</brief_summary>
	<brief_title>Study Determine Administration Sugammadex Impacts Hospital Efficiency</brief_title>
	<detailed_description>Participants study group receive single bolus Sugammadex ( 4.0mg/kg ) prior extubation . In post-anesthesia care unit ( PACU ) , blind safety-assessor use visual analog scale clinically assess post-operative pain . Post-operative nausea vomiting ( PONV ) assess use PONV rating scale every 30 minute PACU discharge . All patient monitor continuous pulse-oximetry .</detailed_description>
	<mesh_term>Neostigmine</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<criteria>Patients schedule open ventral hernia repair open colectomy ASA class IIII 18 year old Subjects body mass index ( BMI ) &lt; 45kg/m2 weight less 150kg Subjects give write informed consent Subjects medical condition and/or undergo surgical procedure compatible use TOFWatchÂ® SX ( e.g. , injury thumbs/distal forearm , bilateral ulnar nerve damage subject cardiac pacemaker Subjects know suspect neuromuscular disorder impair neuromuscular blockade ( e.g. , subject myasthenia gravis ) Subjects know suspected significant renal dysfunction ( e.g . creatinine clearance &lt; 30 mL.min1 Subjects know suspected ( family ) history malignant hyperthermia ; significant hepatic dysfunction Subjects know suspect allergy opiates/opioids , muscle relaxant medication use general anesthesia ; Subjects know suspect hypersensitive Sugammadex cyclodextrins Rocuronium excipients Subjects contraindication , Rocuronium Sugammadex Female subject pregnant Morbidly obese subject BMI &gt; 45 kg/m2 weight 150 kg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>